top of page
Kaleida Capital

Kaleida Capital


    Female focused, Asian focused, Exclude Fossil Fuel, Exclude Tobacco, Exclude Firearms, Focus on DEI, Other: Neuroethics, Science, Longevity

Investment Stage: 

    Pre-Seed, Seed, Series A

Minimum Investment:



    Ai, B2B, Biotech, Computing/Electronics, Consumer, Data Analytics, Education, Health, Life Sciences, Mental Health, Mobility, Robotics, Silvertech, Tech-enabled, Healthtech

About the firm:

Kaleida Capital is building the world’s premier deeptech x life science firm uniquely leveraging neurotechnology to pioneer the next multi-billion dollar life science and consumer markets. With the GP’s best-in-class experience driving $40MM in deep-biotech with 6.5X MOIC in 2 years and expertise as a Stanford PhD-trained Neuroengineer, Kaleida Capital Fund I will deploy $50M into technically-defensible Seed-stage companies at the convergence of Artificial Intelligence (AI), engineering, and neuroscience to maximize impact and liquidity in an untapped yet high demand space.

Learn more about this firm by:

Accepts investors from outside the US:


bottom of page